|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.052 AUD | 0.00% |
|
-11.86% | -16.13% |
| Mar. 25 | Transcript : Prescient Therapeutics Limited - Special Call | |
| Feb. 23 | Prescient Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Prescient Therapeutics Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was AUD 7 million compared to AUD 5.12 million a year ago. Basic loss per share from continuing operations was AUD 0.0096 compared to AUD 0.0079 a year ago.
Diluted loss per share from continuing operations was AUD 0.0096 compared to AUD 0.0079 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.13% | 27.31M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
PRESCIENT THERAPEUTICS LIMITED 
